S’thabiso Bohlela

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

L. Rigouts, T. Heupink, G. Maartens, 2022, Trials.